Baseline level of circulating endothelial progenitors predicts progression-free survival and overall survival in advanced hepatocellular carcinoma patients treated with sorafenib plus metronomic chemotherapy

被引：0
|
作者：
Shao, Yu-Yun
Lin, Zhong-Zhe
Chen, Te-Jung
Chang, Dwan-Ying
Hsu, Chiun
Shen, Ying-Chun
Hsu, Chih-Hung
Cheng, Ann-Lii
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] TTY Bio Pharm Ltd Co, Taipei, Taiwan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
690
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [2] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Arai, Kuniaki
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY, 2013, 58 : 1221A - 1221A
  • [3] Sorafenib Plus Chemotherapy Significantly Prolongs Progression-Free Survival in Advanced Breast Cancer Patients
    不详
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (11): : 931 - 931
  • [4] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [5] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [6] The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Woerns, Marcus A.
    Koch, Sandra
    Niederle, Ina M.
    Marquardt, Jens U.
    Nguyen-Tat, Marc
    Gamstaetter, Thomas
    Schuchmann, Marcus
    Schulze-Bergkamen, Henning
    Galle, Peter R.
    Weinmann, Arndt
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (05) : 408 - 413
  • [7] High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy
    Shao, Yu-Yun
    Lin, Zhong-Zhe
    Chen, Te-Jung
    Hsu, Chiun
    Shen, Ying-Chun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    [J]. ONCOLOGY, 2011, 81 (02) : 98 - 103
  • [8] Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
    Feng, Yu-Min
    Feng, Chin-Wen
    Lu, Chin-Li
    Lee, Ming-Yang
    Chen, Chi-Yi
    Chen, Solomon Chih-Cheng
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 336 - 342
  • [9] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
  • [10] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Bramuzzo, I.
    Gerussi, A.
    Maier, S.
    Bianco, C.
    Romanin, A.
    Pasini, C. Laghi
    Barghini, V.
    Scata, L.
    Donnini, D.
    Uzzau, A.
    Vit, A.
    Sechi, L. A.
    Soardo, G.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
12345